| Target Price | $428.40 |
| Price | $325.00 |
| Potential | 31.82% |
| Number of Estimates | 18 |
| 18 Analysts have issued a price target Teradyne, Inc. 2027 . The average Teradyne, Inc. target price is $428.40. This is 31.82% higher than the current stock price. The highest price target is $577.50 77.69% , the lowest is $272.70 16.09% . | |
| A rating was issued by 22 analysts: 16 Analysts recommend Teradyne, Inc. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Teradyne, Inc. stock has an average upside potential 2027 of 31.82% . Most analysts recommend the Teradyne, Inc. stock at Purchase. |
20 Analysts have issued a sales forecast Teradyne, Inc. 2026 . The average Teradyne, Inc. sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
16 Analysts have issued an Teradyne, Inc. EBITDA forecast 2026. The average Teradyne, Inc. EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
19 Teradyne, Inc. Analysts have issued a net profit forecast 2026. The average Teradyne, Inc. net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird |
Outperform
➜
Neutral
|
Downgrade | Aug 21 2026 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 30 2026 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Jul 30 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Jul 29 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Jul 20 2026 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jul 06 2026 |
| Susquehanna |
Positive
➜
Positive
|
Unchanged | Jun 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
Baird:
Outperform
➜
Neutral
|
Aug 21 2026 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Jul 30 2026 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Jul 30 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Jul 29 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Jul 20 2026 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jul 06 2026 |
|
Unchanged
Susquehanna:
Positive
➜
Positive
|
Jun 30 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


